Brief: Lisata Therapeutics Announces Sponsored Preclinical Research Agreement With The University Of Cincinnati To Study Certepetide For The Treatment Of Endometriosis
28/10/2024 12:55
Oct 28 (Reuters) - Lisata Therapeutics Inc LSTA.O :
* LISATA THERAPEUTICS ANNOUNCES SPONSORED PRECLINICAL
RESEARCH
AGREEMENT WITH THE UNIVERSITY OF CINCINNATI TO STUDY CERTEPETIDE
FOR THE TREATMENT OF ENDOMETRIOSIS
Source text: ID:nGNX96LBgJ
Further company coverage: LSTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Lisata Therapeutics Announces New Method Of Use Patent Granted For Certepetide In The Treatment Of Pancreatic Cancer And Other Solid Tumors
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE -Expeditors International, Waters, Ameresco